Le Marchand L

Latest

Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers
A reply to 'Lung cancer outcomes: Are BMI and race clinically relevant?'
The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients
Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility
Body mass index (BMI), BMI change, and overall survival in patients with SCLC and NSCLC: A pooled analysis of the International Lung Cancer Consortium
Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci
Elevated platelet count appears to be causally associated with increased risk of lung cancer: A Mendelian randomization analysis
Lung cancer risk in never-smokers of European descent is associated With genetic variation in the 5p15.33 TERT-CLPTM1Ll region
Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development
Shared heritability and functional enrichment across six solid cancers
Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity
Genetic modifiers of radon-induced lung cancer risk: A genome-wide interaction study in former uranium miners
Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers
Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population
Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium
Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study
Abstract 2292: Lung function and lung cancer risk: A Mendelian randomization study of UK Biobank cohort and the International Lung Cancer Consortium
Genetic risk can be decreased: Quitting smoking decreases and delays lung cancer for smokers with high and low CHRNA5 risk genotypes — A meta-analysis
Abstract 817: Mendelian randomization and mediation analysis of 5p15.33, telomere length and lung cancer risk
CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis—A meta-analysis
Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium